Search Press releases Keywords From To 12 Jun 2020 First Presentations of Bimekizumab Phase 3 Data Demonstrate Superior Skin Clearance Over Placebo and Stelara[®] at Week 16 in Adults with Moderate-to-Severe Plaque Psoriasis Read More 11 Jun 2020 Acquisitions and disposals of own shares Read More 5 Jun 2020 UCB acquires Engage Therapeutics: Staccato[®] Alprazolam - A potential solution for acute on-demand seizure management for people living with epilepsy Read More 4 Jun 2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress Read More 2 Jun 2020 Acquisitions and disposals of own shares Read More 22 May 2020 Acquisitions of own shares and Disposals of own shares Read More Pagination First page Previous page Previous … Page 61 Page 62 Page 63 Page 64 Current page 65 Page 66 Page 67 Page 68 Page 69 … Page 65 of 70 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
